Myth: Alternative nicotine products don't help people stop smoking: Difference between revisions

Added section for Mil/Vet and study in use of harm reduction in US Air Force young adults
(Added section for Mil/Vet and study in use of harm reduction in US Air Force young adults)
Line 963: Line 963:
*If the patient perceives that the e‐cig is helping them to stay off cigarettes and is not reporting any health problems likely attributable to the e‐cig, then the focus should be on staying smoke‐free rather than e‐cig free.  
*If the patient perceives that the e‐cig is helping them to stay off cigarettes and is not reporting any health problems likely attributable to the e‐cig, then the focus should be on staying smoke‐free rather than e‐cig free.  
*[https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1742-1241.2011.02751.x PDF Version]
*[https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1742-1241.2011.02751.x PDF Version]
<br>
 
== Military/Veterans ==
 
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/37712011/ Motives for using electronic nicotine delivery systems (ENDS) as a cessation tool are associated with tobacco abstinence at 1-year follow-up: A prospective investigation among young adults in the United States Air Force.] ===
 
* Researchers who are willing to push back on the mantra of giving primacy to "FDA authorised smoking cessation treatments" and going with evidence of public health impact as the basis for their conclusions.
* Results: Smokers reporting ENDS use for cigarette cessation were more likely to be abstinent at one-year follow-up (Odds Ratio[OR] = 1.62, 95% CI: 1.06-2.49, P =.03) as well as quit using non-cigarette tobacco products (OR = 2.11, 95% CI: 1.65-2.70, P <.001) than those reporting ENDS use for alternative reasons.
* Conclusions: Current tobacco users are recommended to use FDA-approved products for smoking cessation, such as nicotine replacement therapy. However, given the high prevalence of cigarette use among military populations, ENDS may provide a useful alternative harm reduction strategy for this high-risk population. 
* Aycock CA, Wang XQ, Williams JB, Fahey MC, Talcott GW, Klesges RC, Little MA.Prev Med Rep. 2023 Sep 8;35:102399. doi: 10.1016/j.pmedr.2023.102399. eCollection 2023 Oct. PMID: 37712011
* [https://www.sciencedirect.com/science/article/pii/S2211335523002905/pdfft?md5=867cf8f684964cf79bee181e1ee01a1e&pid=1-s2.0-S2211335523002905-main.pdf PDF Version]


=Jails & Prisons=
=Jails & Prisons=